SCR - Hot Stocks: GSK split PDCO falls on earnings GMTX drops on clinical results TLSA gets COVID trial
Alex Potemkin/iStock Unreleased via Getty Images GlaxoSmithKline (GSK) received a boost in Wednesday's pre-market action on news that it plans to split off its consumer health unit. Traders also have their eyes on gambling names. Moves toward legalization in Canada have put Score Media and Gaming Inc. (SCR) and DraftKings (DKNG) in focus. In other news, Patterson Companies, Inc. (PDCO) posted a double-digit decline in Wednesday's pre-market action, pulled down by a disappointing quarterly report. Gemini Therapeutics (GMTX) also lost significant ground before the bell, hurt by disappointing clinical trial results. Meanwhile, shares of Tiziana Life Sciences (TLSA) moved in the other direction Wednesday morning, as the company inked a deal to conduct a COVID clinical trial in Brazil. GlaxoSmithKline revealed plans to split into two companies. The firm will spin off its consumer health unit as a separate listing. After the transaction, GSK will consist of its pharma business.
For further details see:
Hot Stocks: GSK split, PDCO falls on earnings, GMTX drops on clinical results, TLSA gets COVID trial